Scribe Therapeutics Inc. (SCTX)

NASDAQ: SCTX · Real-Time Price · USD

28.44

-0.40 (-1.39%)

At close: Aug 28, 2026, 4:00 PM EDT

28.00

-0.44 (-1.55%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Scribe Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	20.38	12.8	12.6
Short-Term Investments	29.35	45.17	92.57
Cash & Short-Term Investments	49.73	57.96	105.17
Cash Growth	-	-44.89%	-
Accounts Receivable	1.28	7.09	3.12
Other Receivables	0.24	0.26	0.4
Receivables	1.52	7.35	3.52
Prepaid Expenses	1.15	1.62	1.69
Total Current Assets	52.4	66.93	110.37
Property, Plant & Equipment	9.32	10.07	13.18
Long-Term Deferred Charges	-	0.5	3.6
Other Long-Term Assets	3.49	0.71	0.82
Total Assets	65.21	78.22	127.97

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	5.12	4.57	3.79
Accrued Expenses	4.33	6.71	5.98
Current Portion of Long-Term Debt	40.55	35.34	-
Current Portion of Leases	1.33	1.29	1.12
Current Income Taxes Payable	0.07	-	0.64
Current Unearned Revenue	28.33	21.09	23.41
Other Current Liabilities	-	0.07	0.09
Total Current Liabilities	79.72	69.06	35.02
Long-Term Debt	-	-	34.47
Long-Term Leases	4.46	4.8	6.09
Long-Term Unearned Revenue	11.7	19.94	49.01
Other Long-Term Liabilities	7.71	7.49	8.88
Total Liabilities	103.59	101.28	133.47

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Common Stock	0.01	0.01	0.01
Additional Paid-In Capital	16.3	14.24	9.95
Retained Earnings	-175.05	-157.71	-135.9
Comprehensive Income & Other	-	0.04	0.07
Total Common Equity	-158.74	-143.42	-125.86
Shareholders' Equity	-38.38	-23.06	-5.5
Total Liabilities & Equity	65.21	78.22	127.97

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Total Debt	46.33	41.43	41.68
Net Cash (Debt)	3.4	16.54	63.49
Net Cash Growth	-	-73.96%	-
Net Cash Per Share	1.39	6.81	26.50
Filing Date Shares Outstanding	2.47	2.45	2.42
Total Common Shares Outstanding	2.47	2.45	2.42
Working Capital	-27.32	-2.12	75.36
Book Value Per Share	-64.31	-58.51	-52.06
Tangible Book Value	-158.74	-143.42	-125.86
Tangible Book Value Per Share	-64.31	-58.51	-52.06
Machinery	12.83	12.82	12.39
Leasehold Improvements	4.94	4.94	4.94

SEC Filings: 10-K · 10-Q